Hematologic Oncology Update
Hematologic Oncology Update
✓

Chronic Lymphocytic Leukemia — Microlearning Activity 2

· menunjukkan nota
00:27:51
Podcasts
RSS
Link

MENGENAI EPISOD INI

Featuring perspectives from Dr Catherine C Coombs, including the following topics:

  • Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00)
  • Role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy for relapsed/refractory (R/R) CLL (10:42)
  • Fixed-duration venetoclax in combination with epcoritamab for R/R CLL/SLL; management of Richter’s transformation (15:50)
  • Novel Bruton tyrosine kinase degraders bexobrutideg (NX-5948) and tacabrutideg (BGB-16673) (22:51)

CME information and select publications

Sains
Ubat-ubatan
Bahasa Inggeris
Amerika Syarikat
GunakanAPIuntuk mengambil episod ini dalamJSON

Tunjukkan NOTA 🔗

00:00:00Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
00:10:42Role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy for relapsed/refractory (R/R) CLL
00:15:50Fixed-duration venetoclax in combination with epcoritamab for R/R CLL/SLL; management of Richter’s transformation
00:22:51Novel Bruton tyrosine kinase degraders bexobrutideg (NX-5948) and tacabrutideg (BGB-16673)

TRANSKRIP 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

CARI EPISOD LEPAS

Cari episod lepas bagi Hematologic Oncology Update.
Masukkan bar carian ini ke laman web anda

EPISOD LAIN DALAM PODCAST INI

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

Featuring perspectives from Prof John Seymour and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics: Case: A woman in her mid 50s with multiple sclerosis, hypertension, IGHV-unmutated chronic lymphocytic leukemia (CLL) with an SF3B1 mutatio ...
00:30:54
KONGSI
SIMPAN
Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

Featuring an interview with Prof Andreas Hochhaus, including the following topics: Biology of chronic myeloid leukemia (CML) and rationale for current therapeutic approaches; importance of cytogenetic testing (0:00) Mechanistic differences among first-generation tyrosine kinase inhibitors (TKIs ...
00:59:49
KONGSI
SIMPAN
Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

Featuring perspectives from Dr William G Wierda, including the following topics: Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00) Sequencing Road Map (12:39) Key Datasets — Pirtobrutinib (21:08) Investigator Survey (34:09) Chimeric Antigen Receptor T-Cel ...
00:58:40
KONGSI
SIMPAN
Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov

Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov

Featuring an interview with Dr Douglas W Sborov, including the following topics: DREAMM-2 trial outcomes and clinical development of antibody-drug conjugates for multiple myeloma (MM); mechanism of action of belantamab mafodotin (belamaf) and predictors of response to treatment (0:00) Perspecti ...
00:49:41
KONGSI
SIMPAN
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof John Seymour, including the following topics: Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00) Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21) First-line treatment with sonrot ...
00:22:58
KONGSI
SIMPAN
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Dr. Neil Love, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

SARANAN
Gunakan API untuk mendapatkan episod ini